Antibody Diagnostics

ModiQuest founders developed the first diagnostics test for rheumatoid arthritis, marketed worldwide and included in the American College of Rheumatology (ACR) diagnostics criteria.

Antibody Therapeutics

ModiQuest's pipeline of preclinical candidates includes monoclonal and recombinant antibody therapeutics for prevention and treatment of established rheumatoid arthritis.

About ModiQuest

Experts in monoclonal and recombinant antibody generation for autoimmune and oncology, with high throughput hybridoma and phage display technology.

Latest News

• IMMUNOPRECISE INCREASES PRIVATE PLACEMENT FINANCING
• IMMUNOPRECISE ANNOUNCES PRIVATE PLACEMENT FINANCING
• Immunoprecise Appoints Jennifer Bath to Board of Directors and Expands Senior Leadership to Further Global Growth
• Immunoprecise Opens U.S. Headquarters in Fargo, North Dakota